Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of molecular markers for predicting therapy response in cancer patients.

Cancer treatment reviews - 1 Apr 2011

Duffy Michael J, O'Donovan Norma, Crown John

Abstract excerpt

Predictive markers are factors that are associated with upfront response or resistance to a particular therapy. Predictive markers are important in oncology as tumors of the same tissue of origin vary widely in their response to most available systemic therapies. Currently recommended oncological predictive markers include both estrogen and progesterone receptors for identifying patients with breast cancers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Lapatinib
Share to Quinazolines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Tamoxifen

Share to Trastuzumab

Source

Identifiers

PMID: 20685042
DOI: 10.1016/j.ctrv.2010.07.004

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of molecular markers for predicting therapy response in cancer patients.PMID 20685042Read ↗

Companion biomarkers: paving the pathway to personalized treatment for cancer.Semantic proximity Read ↗

Cancer molecular markers: A guide to cancer detection and management.Semantic proximity Read ↗

Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.Semantic proximity Read ↗

Diagnostic and prognostic molecular markers in cancer.Semantic proximity Read ↗

Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevanceSemantic proximity Read ↗

The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancerSemantic proximity Read ↗

Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.Semantic proximity Read ↗

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.Semantic proximity Read ↗

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.Semantic proximity Read ↗

Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendationsSemantic proximity Read ↗

Breast cancer biomarkers and molecular medicine.Semantic proximity Read ↗

Prognostic and predictive biomarkers: tools in personalized oncology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.